Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope

Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England

(2021) Giuseppe Boriani et al.   VALUE IN HEALTH

Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator

(2020) Moritz Hadwiger et al.   Applied Health Economics and Health Policy

Seventeen-year trend (2001–2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: An analysis by age groups

(2020) Massimo Zecchin et al.   European Journal of Internal Medicine

Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study

(2019) Fozia Zahir Ahmed et al.   PLoS One

Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis

(2019) Emma Burnhope et al.   JOURNAL OF MEDICAL ECONOMICS

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection

(2019) Khaldoun G. Tarakji et al.   NEW ENGLAND JOURNAL OF MEDICINE

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

(2019) Carina Blomström-Lundqvist et al.   EUROPACE

Risk Factors for Infections Involving Cardiac Implanted Electronic Devices

(2019) David H. Birnie et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study

(2018) Nicolas Clémenty et al.   EUROPACE

Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection

(2018) Arnold J. Greenspon et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review

(2018) David Cameron et al.   Global Health Action

Incidence and costs of cardiac device infections: retrospective analysis using German health claims data

(2018) Saskia Ludwig et al.   Journal of Comparative Effectiveness Research

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

(2018) Gemma Kay et al.   JOURNAL OF MEDICAL ECONOMICS

Economic evaluations and their use in infection prevention and control: a narrative review

(2018) Elissa Rennert-May et al.   Antimicrobial Resistance and Infection Control

Real-world costs of transvenous lead extraction: the challenge for reimbursement

(2018) Claire E P Brough et al.   EUROPACE

The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective

(2017) Martin R. Cowie et al.   EUROPEAN JOURNAL OF HEART FAILURE

Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey

(2017) Maximilian H. M. Hatz et al.   HEALTH ECONOMICS

Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure

(2017) Michael R. Gold et al.   JACC-Heart Failure

Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)

(2016) Khaldoun G. Tarakji et al.   AMERICAN HEART JOURNAL

Cost–effectiveness thresholds: pros and cons

(2016) Melanie Y Bertram et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection

(2016) M. Rizwan Sohail et al.   Circulation-Arrhythmia and Electrophysiology

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure

(2016) Stuart Mealing et al.   HEART

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

(2016) Thomas Wilkinson et al.   VALUE IN HEALTH

Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure

(2016) Alexander T. Sandhu et al.   JACC-Heart Failure

Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation

(2015) NASIR SHARIFF et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Rates of and Factors Associated With Infection in 200 909 Medicare Implantable Cardioverter-Defibrillator Implants

(2014) Jordan M. Prutkin et al.   CIRCULATION

Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival

(2014) K. G. Tarakji et al.   EUROPACE

A simple infection-control protocol to reduce serious cardiac device infections

(2014) S. Y. Ahsan et al.   EUROPACE

Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)

(2014) Jonathan A. T. Sandoe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

(2014) Jeffrey L. Anderson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Increased Long-Term Mortality in Patients with Cardiovascular Implantable Electronic Device Infections

(2014) MUHAMMAD RIZWAN SOHAIL et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions

(2013) Douglas K. Owens   ANNALS OF INTERNAL MEDICINE

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association

(2013) G. Boriani et al.   EUROPEAN HEART JOURNAL

From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction

(2013) Igor Diemberger et al.   Expert Review of Medical Devices

Mortality and Cost Associated With Cardiovascular Implantable Electronic Device Infections

(2011) Muhammad R. Sohail   ARCHIVES OF INTERNAL MEDICINE

Economic evaluation in cardiology

(2011) N. Maniadakis et al.   EUROPACE

Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology

(2011) G. Fattore et al.   EUROPACE

From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter–defibrillator systems

(2011) Igor Diemberger et al.   Expert Review of Medical Devices

16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States

(2011) Arnold J. Greenspon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The 11th World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators: Calendar Year 2009-A World Society of Arrhythmia's Project

(2011) HARRY G. MOND et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Continued Rise in Rates of Cardiovascular Implantable Electronic Device Infections in the United States: Temporal Trends and Causative Insights

(2009) ANDREW VOIGT et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard

(2008) Chris P. Lee et al.   VALUE IN HEALTH